Our results confirm correlations between heterogeneous Gal8 immunoexpression and several clinicopathological characteristics (tumor size, lympho-vascular invasion, and lymph node metastasis), meaning that different tissue levels of Gal8 could lead to different tumor behaviors. Here, LGALS8 is linked to neoplasm.